ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 24862628

Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men.

Zhang X and 5 others. Urol Int, 2014. Cited by 38 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men. Papers, record 24862628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24862628

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men.
PubMed
Journal
Urol Int
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.96
iCite
Revised in PubMed
2022-12-07
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang XXiangyu
2Zeng XXiaofang
3Liu YYing
4Dong LLini
5Zhao XXiaokun
6Qu XXiaobing

Source PubMed

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Asian PeopleMajor topic
Metabolic SyndromeMajor topic
Prostatic HyperplasiaMajor topic
Age Factors
Aged
Aged, 80 and over
Biomarkers
Body Mass Index
China
Cholesterol, HDL
Dyslipidemias
Humans
Insulin
Insulin Resistance
Linear Models
Male
Middle Aged
Obesity
Organ Size
Prostate
Risk Factors

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in24,862,845Editorial comment on Zhang et al.: Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men.https://conductscience.org/library/papers/24862845

Source PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
41,928,554The Association Between Metabolic Syndrome and Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.Am J Mens Health2026https://conductscience.org/library/papers/41928554PubMed
40,955,380Association between insulin resistance and prostate volume: A 4-year analysis from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial.BJUI Compass2025https://conductscience.org/library/papers/40955380PubMed
39,774,061Age-related changes in the impact of metabolic syndrome on prostate volume: a cross-sectional study.Asian J Androl2025https://conductscience.org/library/papers/39774061PubMed
37,877,834The Relationship Between Metabolic Syndrome and Benign Prostate Enlargement: A Case-Control Study in a Peruvian Military Hospital.Urol Res Pract2023https://conductscience.org/library/papers/37877834PubMed
37,569,882Molecular Mechanisms Underlying Chronic and Degenerative Diseases.Int J Mol Sci2023https://conductscience.org/library/papers/37569882PubMed
35,691,993Simvastatin inhibits prostatic hyperplasia in rats with metabolic syndrome.Int Urol Nephrol2022https://conductscience.org/library/papers/35691993PubMed
34,900,218Metabolic syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors.Ther Adv Endocrinol Metab2021https://conductscience.org/library/papers/34900218PubMed
31,966,724Associations of SRD5A2/CYP17/CYP19/VDR gene polymorphisms with the development and clinical progression of benign prostatic hyperplasia: a case-control study in northern Chinese population.Int J Clin Exp Pathol2017https://conductscience.org/library/papers/31966724PubMed
31,612,766Association between benign prostate hyperplasia and metabolic syndrome in men under 60 years old: a meta-analysis.J Int Med Res2019https://conductscience.org/library/papers/31612766PubMed
30,122,909Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders.Clin Interv Aging2018https://conductscience.org/library/papers/30122909PubMed

1 to 10 of 19

See all 19 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
INS3,630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24862628

GET https://conductscience.org/api/papers/v1/24862628/authors

API referenceFor AI assistants